Ganciclovir

Common brands: Zirgan, Prograf, Envarsus Xr, Cellcept, Tacrolimus

Top reporter: Bausch & Lomb Incorporated

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Nucleoside Analog Antiviral [EPC]Corticosteroid [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Azole Antifungal [EPC]
10,024
Total Reports
5,641
Serious Reports
3,081
Death Reports
30
Reported Reactions
Death Report Ratio: High (30.74%)

Patient Demographics

Male
5,003
Female
3,704

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ganciclovir.

# Reaction Reports % of Total
1 OFF LABEL USE 1,602
11.3%
2 DRUG INEFFECTIVE 1,417
10.0%
3 CYTOMEGALOVIRUS INFECTION 1,188
8.4%
4 DRUG RESISTANCE 665
4.7%
5 PYREXIA 595
4.2%
6 PRODUCT USE IN UNAPPROVED INDICATION 550
3.9%
7 NEUTROPENIA 512
3.6%
8 PANCYTOPENIA 510
3.6%
9 DIARRHOEA 436
3.1%
10 CYTOMEGALOVIRUS VIRAEMIA 422
3.0%
11 PNEUMONIA 418
3.0%
12 SEPSIS 409
2.9%
13 MULTIPLE ORGAN DYSFUNCTION SYNDROME 393
2.8%
14 RESPIRATORY FAILURE 384
2.7%
15 CYTOMEGALOVIRUS INFECTION REACTIVATION 366
2.6%
16 THROMBOCYTOPENIA 355
2.5%
17 LEUKOPENIA 345
2.4%
18 CONDITION AGGRAVATED 324
2.3%
19 RENAL IMPAIRMENT 320
2.3%
20 ACUTE KIDNEY INJURY 310
2.2%
21 PRODUCT USE ISSUE 307
2.2%
22 PATHOGEN RESISTANCE 295
2.1%
23 RENAL FAILURE 284
2.0%
24 ANAEMIA 280
2.0%
25 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 256
1.8%
26 SEPTIC SHOCK 255
1.8%
27 EPSTEIN-BARR VIRUS INFECTION 252
1.8%
28 NEPHROPATHY TOXIC 240
1.7%
29 TRANSPLANT REJECTION 222
1.6%
30 GRAFT VERSUS HOST DISEASE 219
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.